Westbourne Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,851
Closed -$606K 142
2025
Q4
$606K Buy
1,851
+51
+3% +$16.2K 0.28% 75
2025
Q3
$537K Sell
1,800
-25
-1% -$7.25K 0.26% 74
2025
Q2
$510K Sell
1,825
-100
-5% -$28.3K 0.27% 75
2025
Q1
$600K Buy
1,925
+100
+5% +$29.5K 0.36% 66
2024
Q4
$476K Buy
+1,825
New +$541K 0.28% 74

Other funds holding AMGN

Westbourne Investments's AMGN Position: Q1 2026 in Review

Westbourne Investments sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,851 shares — an estimated $606K sold.

Westbourne Investments first reported a position in AMGN in Q4 2024 and held it in 5 quarters. The position peaked at $606K in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Westbourne Investments reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Westbourne Investments sold 1,851 Amgen shares in Q1 2026, an estimated $606K.
  • Westbourne Investments first reported a position in Amgen in Q4 2024 and held it in 5 quarters.
  • Westbourne Investments's Amgen position peaked at $606K in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Westbourne Investments's 13F filing for Q1 2026, filed 15 May 2026.